Brief Title
DNA Methylation Biomarkers for Cervical Cancer Screening
Official Title
DNA Methylation Biomarkers for Cervical Cancer Screening
Brief Summary
The purpose of this prospective study is to evaluate whether DNA methylation can be applied in cervical cancer screening.
Study Type
Observational
Primary Outcome
Performance of DNA methylation in identification of CIN3 or worse.
Condition
Cervical Intraepithelial Neoplasia
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Estimated Enrollment
5000
Start Date
February 2014
Completion Date
August 2016
Primary Completion Date
December 2015
Eligibility Criteria
Inclusion Criteria: - women with age ≥20 and sexual experience - Agree to sign ICF Exclusion Criteria: - women had received Hysterectomy - women had destructive therapy for cervical lesions in 6 months, for examples: conization, Laser or cryotherapy, chemotherapy, and radiation therapy - Women are at pregnancy or had baby delivery in 6 weeks
Gender
Female
Ages
20 Years - N/A
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Contacts
Yuh-cheng Yang, MD, +886-2-2696-3518, [email protected]
Location Countries
Taiwan
Location Countries
Taiwan
Administrative Informations
NCT ID
NCT02605941
Organization ID
epigene-13151
Responsible Party
Sponsor
Study Sponsor
iStat Biomedical CO., Ltd.
Collaborators
Mackay Memorial Hospital
Study Sponsor
Yuh-cheng Yang, MD, Study Chair, Mackay Memorial Hospital
Verification Date
November 2015